SEC Form 4 · accession 0000886163-15-000008
LIGAND PHARMACEUTICALS INC · LGND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Charles S Berkman
Officer — VP, Gen. Counsel & Secretary
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 7:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 31, 2014 | P | 126 | $45.2285 | A | 27,433 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares Acquired under Ligand's employee stock purchase plan.